ML-004 (IR)/(ER) tablet
ML-004-003
Phase 2 small_molecule active
Quick answer
ML-004 (IR)/(ER) tablet for Autism Spectrum Disorder is a Phase 2 program (small_molecule) at MapLight Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- MapLight Therapeutics
- Indication
- Autism Spectrum Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active